NASDAQ: ICCC - ImmuCell Corporation

छह महीने के लिए लाभप्रदता: +21.46%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम ImmuCell Corporation

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus.

अधिक जानकारी
The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 1987-04-30
ISIN US4525253062
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://immucell.com
Цена ао 5.16
प्रति दिन मूल्य परिवर्तन: +4.84% (4.75)
प्रति सप्ताह मूल्य परिवर्तन: +12.93% (4.41)
प्रति माह मूल्य परिवर्तन: +33.87% (3.72)
3 महीने में कीमत में बदलाव: +40.28% (3.55)
छह महीने में कीमत में बदलाव: +21.46% (4.1)
प्रति वर्ष मूल्य परिवर्तन: -2.16% (5.09)
3 वर्षों में मूल्य परिवर्तन: -43.34% (8.79)
5 वर्षों में मूल्य परिवर्तन: -0.2004% (4.99)
10 वर्षों में मूल्य परिवर्तन: 0% (4.98)
वर्ष की शुरुआत से मूल्य परिवर्तन: +34.59% (3.7)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 2.08 7
P/BV 1.45 9
P/E 0 0
EV/EBITDA -17.15 0
कुल: 5.5

क्षमता

नाम अर्थ श्रेणी
ROA, % -13.18 0
ROE, % -23.1 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -5.51 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 27.53 4
लाभप्रदता Ebitda, % 162.48 10
लाभप्रदता EPS, % 292.07 10
कुल: 8.8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Vanguard Group Inc 206606 2.67
Renaissance Technologies, LLC 126189 1.63
Cresset Asset Management, LLC 103606 1.34
Bleichroeder LP 101594 1.31
Morgan Stanley 84574 1.09
Shufro, Rose & Co., LLC 62408 0.81
Dimensional Fund Advisors LP 57451 0.74
Geode Capital Management, LLC 53213 0.69
Susquehanna International Group, LLP 33720 0.44
Overbrook Management Corp 32857 0.42

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
iShares Micro-Cap ETF 0.00524 17.09 1.54048
Dimensional U.S. Targeted Value ETF 0.00039 26.01 1.93487
Dimensional U.S. Core Equity 2 ETF 0 30.76 1.47098



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Michael F. Brigham President, CEO, Principal Financial Officer, Treasurer, Secretary & Director 395.24k 1961 (64 वर्ष)
Ms. Bobbi Jo Brockmann VP of Sales & Marketing and Director 323.52k 1977 (48 साल)
Mr. A. Gustavo Scaffa Senior Director of Quality N/A
John W. Zinckgraf Director of Product Development N/A
Ms. Elizabeth L. Williams Vice President of Manufacturing Operations 312.07k 1956 (69 साल)
Ms. Elizabeth S. Toothaker Director of Finance & Administration and Controller N/A

पता: United States, Portland. ME, 56 Evergreen Drive - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://immucell.com